Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
September 5, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for June 26, 2007 Subscribe to this News Feed      
 

Paxil Resource Web Site Launched by Williams Kherkher

Williams Kherkher launch a Paxil Resource web site in response to the prescription drug, paxil.

Houston, TX (PRWEB) June 26, 2007 -- In response to recent news regarding the prescription drug Paxil, Williams Kherkher of Houston, Texas has launched a complete Web site, whose URL is Paxil.

Williams Kherkher is led by Attorneys John Eddie Williams and Steve Kherkerk, and has 26 attorneys and over 120 support staff and has worked in the area of mass tort litigation since 1983.

Paxil is manufactured by SmithKline Beecham, and is part of the same drug "family" as Prozac, Zoloft, Luvox and Celexa, all of which are considered "SSRI's," which stands for Selective Serotonin Reuptake Inhibitors. Paxil's primary use is to help treat depression. Several lawsuits have resulted from the discovery of these problems, and one class action lawsuit, Hoormann v. SmithKlineBeecham, Case No.04-L-715 in the Third Judicial Circuit for the State of Illinois, recently settled for $63.8 million.

As early as 2005, the Food and Drug Administration (FDA) published a warning on its Web site stating that Paxil was linked to the following side effects:

  • birth defects
  • restlessness
  • hallucinations
  • loss of coordination
  • fast heart beat
  • increased body temperature
  • fast changes in blood pressure
  • overactive reflexes
  • diarrhea
  • coma
  • nausea
  • vomiting

Paxil has also been found to be addictive, and there have even been allegations that the company suppressed data that showed Paxil to be a high risk for children and adolescents.

In regards to the birth defects link, the women who are most at risk are those in their first three months of pregnancy, and the specific birth defect that's been found to be most prevalent is a heart defect, but the FDA also warned that no one should simply stop taking the drug without the involvement of their medical doctors.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/TWFnbi1aZXRhLVN1bW0tQ291cC1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Joe Devine
Williams Kherkher
5125734183
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright